Export

EN
FR
Budesonide + formoterol
Essential medicine status
Section:
25. Medicines acting on the respiratory tract 25.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease
ATC codes: R03AK07
Indication
Asthma ICD11 code: CA23
INN
Budesonide + formoterol
Medicine type
Chemical agent
List type
Core
Formulations
Respiratory > Inhalation > powder: 100 µg + 6 µg per dose actuation in dry powder inhaler ; 200 µg + 6 µg per dose actuation in dry powder inhaler
EML status history
First added in 2017 (TRS 1006)
Changed in 2021 (TRS 1035)
Changed in 2025 (TRS 1064)
Sex
All
Age
Adolescents and adults
Therapeutic alternatives
budesonide + salmeterol (ATC codes: R03AK12)
beclometasone + formoterol (ATC codes: R03AK08)
mometasone + formoterol (ATC codes: R03AK09)
fluticasone + formoterol (ATC codes: R03AK11)
fluticasone furoate + vilanterol (ATC codes: R03AK10)
Patent information
Patents have expired in most jurisdictions
Wikipedia
Budesonide + formoterol
DrugBank
Budesonide ,
Formoterol
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations of essential medicines for children, the Expert Committee recommended the following changes to the listing of budesonide + formoterol on the EML: - update the listing description of inhalation delivery systems for consistency across the Model Lists and to better reflect product characteristics.